These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 26151543

  • 1. Current status of Bacille Calmette Guérin (BCG) immunisation in Europe - A ptbnet survey and review of current guidelines.
    Dierig A, Tebruegge M, Krivec U, Heininger U, Ritz N, Paediatric Tuberculosis Network European Trials group (ptbnet).
    Vaccine; 2015 Sep 11; 33(38):4994-9. PubMed ID: 26151543
    [Abstract] [Full Text] [Related]

  • 2. The impact of Bacille Calmette-Guérin shortage on immunisation practice and policies in Europe - A Paediatric Tuberculosis Network European Trials Group (ptbnet) survey.
    Kontturi A, Santiago B, Tebruegge M, von Both U, Salo E, Ritz N, Ptbnet BCG shortage project collaborators, on behalf of the Paediatric Tuberculosis Network European Trials Group (ptbnet).
    Tuberculosis (Edinb); 2016 Dec 11; 101():125-129. PubMed ID: 27865381
    [Abstract] [Full Text] [Related]

  • 3. To BCG or not to BCG? Preventing travel-associated tuberculosis in children.
    Ritz N, Connell TG, Curtis N.
    Vaccine; 2008 Nov 05; 26(47):5905-10. PubMed ID: 18804139
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of bacille Calmette-Guérin immunisation programs in Australia.
    Khandaker G, Beard FH, Dey A, Coulter C, Hendry AJ, Macartney KK.
    Commun Dis Intell Q Rep; 2017 Mar 31; 41(1):E33-E48. PubMed ID: 28385137
    [Abstract] [Full Text] [Related]

  • 5. To TST or not to TST: is tuberculin skin testing necessary before BCG immunisation in children?
    Ritz N, Tebruegge M, Camacho-Badilla K, Haeusler GM, Connell TG, Curtis N.
    Vaccine; 2012 Feb 14; 30(8):1434-6. PubMed ID: 22155145
    [Abstract] [Full Text] [Related]

  • 6. The influence of bacille Calmette-Guerin vaccine strain on the immune response against tuberculosis: a randomized trial.
    Ritz N, Dutta B, Donath S, Casalaz D, Connell TG, Tebruegge M, Robins-Browne R, Hanekom WA, Britton WJ, Curtis N.
    Am J Respir Crit Care Med; 2012 Jan 15; 185(2):213-22. PubMed ID: 22071384
    [Abstract] [Full Text] [Related]

  • 7. European survey of BCG vaccination policies and surveillance in children, 2005.
    Infuso A, Falzon D, EuroTB network.
    Euro Surveill; 2006 Jan 15; 11(3):6-11. PubMed ID: 16567882
    [Abstract] [Full Text] [Related]

  • 8. Adverse events following immunisation with bacille Calmette-Guérin vaccination: baseline data to inform monitoring in Australia following introduction of new unregistered BCG vaccine.
    Hendry AJ, Dey A, Beard FH, Khandaker G, Hill R, Macartney KK.
    Commun Dis Intell Q Rep; 2016 Dec 24; 40(4):E470-E474. PubMed ID: 28043221
    [Abstract] [Full Text] [Related]

  • 9. Mapping the global use of different BCG vaccine strains.
    Ritz N, Curtis N.
    Tuberculosis (Edinb); 2009 Jul 24; 89(4):248-51. PubMed ID: 19540166
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui.
    Lanckriet C, Lévy-Bruhl D, Bingono E, Siopathis RM, Guérin N.
    Int J Epidemiol; 1995 Oct 24; 24(5):1042-9. PubMed ID: 8557438
    [Abstract] [Full Text] [Related]

  • 11. Comparable CD4 and CD8 T cell responses and cytokine release after at-birth and delayed BCG immunisation in infants born in Australia.
    Ritz N, Casalaz D, Donath S, Tebruegge M, Dutta B, Connell TG, Robins-Browne R, Britton WJ, Hanekom WA, Curtis N.
    Vaccine; 2016 Jul 29; 34(35):4132-4139. PubMed ID: 27396518
    [Abstract] [Full Text] [Related]

  • 12. Risk factors associated with latent tuberculosis infection in Mexican American children.
    Young J, O'Connor ME.
    Pediatrics; 2005 Jun 29; 115(6):e647-53. PubMed ID: 15930191
    [Abstract] [Full Text] [Related]

  • 13. [The bacille Calmette-Guérin vaccine may reduce the general child morbidity].
    Nissen TN, Thøstesen LM, Birk NM, Pihl G, Kjærgaard J, Stensballe LG.
    Ugeskr Laeger; 2014 Apr 28; 176(9):. PubMed ID: 25096560
    [Abstract] [Full Text] [Related]

  • 14. Neonatal BCG vaccination in Ireland: evidence of its efficacy in the prevention of childhood tuberculosis.
    Kelly P, McKeown D, Clancy L.
    Eur Respir J; 1997 Mar 28; 10(3):619-23. PubMed ID: 9072995
    [Abstract] [Full Text] [Related]

  • 15. Modelling the effect of discontinuing universal Bacillus Calmette-Guérin vaccination in an intermediate tuberculosis burden setting.
    Fu H, Lin HH, Hallett TB, Arinaminpathy N.
    Vaccine; 2018 Sep 18; 36(39):5902-5909. PubMed ID: 30143270
    [Abstract] [Full Text] [Related]

  • 16. The BCG vaccine: information and recommendations for use in Australia.
    National Tuberculosis Advisory Committee.
    Commun Dis Intell Q Rep; 2006 Sep 18; 30(1):109-15. PubMed ID: 16637239
    [Abstract] [Full Text] [Related]

  • 17. The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children.
    Hesseling AC, Marais BJ, Gie RP, Schaaf HS, Fine PE, Godfrey-Faussett P, Beyers N.
    Vaccine; 2007 Jan 02; 25(1):14-8. PubMed ID: 16959383
    [Abstract] [Full Text] [Related]

  • 18. The effect of Bacille Calmette-Guérin vaccine on tuberculin reactivity in indigenous children from communities with high prevalence of tuberculosis.
    Araujo Z, de Waard JH, de Larrea CF, Borges R, Convit J.
    Vaccine; 2008 Oct 16; 26(44):5575-81. PubMed ID: 18723065
    [Abstract] [Full Text] [Related]

  • 19. BCG vaccine: WHO position paper, February 2018 - Recommendations.
    World Health Organization.
    Vaccine; 2018 Jun 07; 36(24):3408-3410. PubMed ID: 29609965
    [Abstract] [Full Text] [Related]

  • 20. Epidemiology of childhood tuberculosis after ceasing universal Bacillus Calmette-Guérin vaccination.
    Kobayashi S, Yoshiyama T, Uchimura K, Hamaguchi Y, Kato S.
    Sci Rep; 2021 Aug 05; 11(1):15902. PubMed ID: 34354146
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.